-
公开(公告)号:US09034921B2
公开(公告)日:2015-05-19
申请号:US14122836
申请日:2012-06-01
申请人: Soongyu Choi , Kwang Seop Song , Suk Ho Lee , Min Ju Kim , Hee Jeong Seo , Eun-Jung Park , Younggyu Kong , So Ok Park , Hyunku Kang , Myung Eun Jung , Kinam Lee , Hyun Jung Kim , Jun Sung Lee , Min Woo Lee , Mi-Soon Kim , Dong Ho Hong , Misuk Kang
发明人: Soongyu Choi , Kwang Seop Song , Suk Ho Lee , Min Ju Kim , Hee Jeong Seo , Eun-Jung Park , Younggyu Kong , So Ok Park , Hyunku Kang , Myung Eun Jung , Kinam Lee , Hyun Jung Kim , Jun Sung Lee , Min Woo Lee , Mi-Soon Kim , Dong Ho Hong , Misuk Kang
IPC分类号: A61K31/351 , C07D407/04 , C07D309/10 , C07D405/10 , C07D407/10 , C07D407/14 , C07D409/04 , C07D409/10 , C07D411/10 , C07D413/04 , C07D405/14 , C07D413/10
CPC分类号: C07D309/10 , C07D405/10 , C07D405/14 , C07D407/04 , C07D407/10 , C07D407/14 , C07D409/04 , C07D409/10 , C07D409/14 , C07D411/10 , C07D413/04 , C07D413/10 , C07D413/12 , C07D413/14
摘要: A compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney is disclosed. A pharmaceutical composition including the compound as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes is disclosed. A method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound is provided.
摘要翻译: 公开了具有对钠依赖性葡萄糖转运蛋白2(SGLT2)具有抑制活性的二苯基甲烷部分的化合物存在于肠和肾中。 公开了包含该化合物作为活性成分的药物组合物,其可用于预防或治疗代谢紊乱,特别是糖尿病。 提供了制备该化合物的方法,以及通过使用该化合物预防或治疗代谢紊乱,特别是糖尿病的方法。
-
公开(公告)号:US20140088079A1
公开(公告)日:2014-03-27
申请号:US14122836
申请日:2012-06-01
申请人: Soongyu Choi , Kwang Seop Song , Suk Ho Lee , Min Ju Kim , Hee Jeong Seo , Eun-Jung Park , Younggyu Kong , So Ok Park , Hyunku Kang , Myung Eun Jung , Kinam Lee , Hyun Jung Kim , Jun Sung Lee , Min Woo Lee , Mi-Soon KIM , Dong Ho Hong , Misuk Kang
发明人: Soongyu Choi , Kwang Seop Song , Suk Ho Lee , Min Ju Kim , Hee Jeong Seo , Eun-Jung Park , Younggyu Kong , So Ok Park , Hyunku Kang , Myung Eun Jung , Kinam Lee , Hyun Jung Kim , Jun Sung Lee , Min Woo Lee , Mi-Soon KIM , Dong Ho Hong , Misuk Kang
IPC分类号: C07D309/10 , C07D405/10 , C07D413/04 , C07D409/10 , C07D413/10 , C07D405/14 , C07D407/04 , C07D407/10
CPC分类号: C07D309/10 , C07D405/10 , C07D405/14 , C07D407/04 , C07D407/10 , C07D407/14 , C07D409/04 , C07D409/10 , C07D409/14 , C07D411/10 , C07D413/04 , C07D413/10 , C07D413/12 , C07D413/14
摘要: The present invention relates to a compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. The present invention also provides a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound.
摘要翻译: 本发明涉及具有对存在于肠和肾中的钠依赖性葡萄糖协同转运蛋白2(SGLT2)具有抑制活性的二苯基甲烷部分的化合物和包含其作为活性成分的药物组合物,其可用于预防 或治疗代谢紊乱,特别是糖尿病。 本发明还提供了一种制备该化合物的方法,以及通过使用该化合物来预防或治疗代谢紊乱,特别是糖尿病的方法。
-